Human CCL5/RANTES Quantikine ELISA Kit
Human CCL5/RANTES Quantikine ELISA Kit
 
	
	Human CCL5/RANTES Quantikine ELISA Kit Summary
	深圳子科生物优势代理美国R&DELISA系列产品试剂盒,价格优势,货期短,欢迎来电咨询0755-33164177!
	货号:DRN00B
	
	
		
		
			
				Sample Type & Volume Required Per Well
			
			
				Cell Culture Supernates (100 uL), Serum (100 uL), EDTA Plasma (100 uL), Heparin Plasma (100 uL), Citrate Plasma (100 uL), Urine (100 uL)
			
		 
		
		
			
				Assay Range
			
			
				31.2 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma, Urine)
			
		 
		
			
				Specificity
			
			
				Natural and recombinant human RANTES
			
		 
		
			
				Cross-reactivity
			
			
				< 0.5% cross-reactivity observed with available related molecules.< 50% cross-species reactivity observed with species tested.
			
		 
		
			
				Interference
			
			
				No significant interference observed with available related molecules.
			
		 
	 
 
	
	
		Product Summary
	
	
		The Quantikine Human RANTES Immunoassay is a 3.5 hour solid phase ELISA designed to measure human RANTES levels in cell culture supernates, serum, plasma, and urine. It contains E. coli-derived recombinant human RANTES and antibodies raised against the recombinant factor. This immunoassay has been shown to accurately quantitate the recombinant factor. Results obtained using natural human RANTES showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values of natural human RANTES.
	
 
	
		Precision
	
	
		Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision
	
	
		Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision
	
	
		Cell Culture Supernates, Serum, Urine
	
	
		
			
				|  | Intra-Assay Precision | Inter-Assay Precision | 
		
		
			
				| Sample | 1 | 2 | 3 | 1 | 2 | 3 | 
			
				| n | 20 | 20 | 20 | 20 | 20 | 20 | 
			
				| Mean | 91.9 | 573 | 1120 | 92 | 511 | 1105 | 
			
				| Standard Deviation | 2.3 | 10 | 32.4 | 6.2 | 32.7 | 70.7 | 
			
				| CV% | 2.5 | 1.7 | 2.9 | 6.7 | 6.4 | 6.4 | 
		
	
	
		EDTA Plasma, Heparin Plasma, Citrate Plasma
	
	
		
			
				|  | Intra-Assay Precision | Inter-Assay Precision | 
		
		
			
				| Sample | 1 | 2 | 3 | 1 | 2 | 3 | 
			
				| n | 20 | 20 | 20 | 20 | 20 | 20 | 
			
				| Mean | 108 | 599 | 1191 | 88 | 494 | 1063 | 
			
				| Standard Deviation | 3.9 | 14.3 | 41.5 | 9.1 | 43.1 | 89.6 | 
			
				| CV% | 3.6 | 2.4 | 3.5 | 10.3 | 8.7 | 8.4 | 
		
	
 
	
		Recovery
	
	
		
			The recovery of RANTES spiked to levels throughout the range of the assay in various matrices was evaluated.
		
	 
	
		
			
				| Sample Type | Average % Recovery | Range % | 
		
		
			
				| Cell Culture Media (n=4) | 101 | 95-110 | 
			
				| Platelet-poor Citrate Plasma (n=4) | 99 | 93-105 | 
			
				| Platelet-poor EDTA Plasma (n=4) | 98 | 93-103 | 
			
				| Platelet-poor Heparin Plasma (n=4) | 99 | 93-105 | 
			
				| Serum (n=5) | 101 | 94-107 | 
			
				| Urine (n=10) | 102 | 88-114 | 
		
	
 
	
		Linearity
	
	
		To assess the linearity of the assay, samples containing and/or spiked with high concentrations of RANTES were serially diluted with the appropriate Calibrator Diluent to produce samples with values within the dynamic range of the assay.